Therapeutics: Toll-interleukin 1 receptor (TIR) domain containing adaptor protein (TIRAP); toll-like receptor 2 (TLR2)

In vitro and mouse studies suggest a peptide derived from the TIR domain of TLR2 could help treat influenza infection. In human cell-based assays, screening of a peptide library derived from the TLR2 ...